Literature DB >> 30680474

Expression analysis of long non-coding RNAs and their target genes in multiple sclerosis patients.

Maziar Ganji1, Arezou Sayad2,3, Mir Davood Omrani1,4, Shahram Arsang-Jang5, Mehrdokht Mazdeh6, Mohammad Taheri7.   

Abstract

Multiple sclerosis (MS) is a progressive chronic autoimmune-mediated disease. Recently, long non-coding RNAs (lncRNAs) are characterized to participate in the adjustment of immune responses. Here, we evaluated the expression levels of GSTT1-AS1 and IFNG-AS1 lncRNAs and their targets (TNF and IFNG, respectively) in Iranian MS patients.In this case-control study, 50 relapsing-remitting MS patients and 50 healthy subjects were recruited. Expressions of GSTT1-AS1 and IFNG-AS1 lncRNAs, as well as TNF and IFNG genes, were assessed in their peripheral blood samples by SYBR Green-based Real-time quantitative PCR.Expression levels of GSTT1-AS1 and IFNG-AS1 lncRNAs were both significantly downregulated (p values 0.032 and 0.013, respectively). On the other hand, the expression of TNF and IFNG showed increased levels, however, did not reach statistical significance after our analysis (p > 0.05). Spearman correlation analysis showed that GSTT1-AS1 had a significant positive moderate correlation with IFNG-AS1 (r = 0.541, p < 0.0001), IFNG (r = 0.329, p = 0.001), and TNF (r = 0.204, p = 0.041). Also, IFNG-AS1 revealed the same correlation with IFNG (r = 0.475, p < 0.0001) as well as TNF (r = 0.399, p < 0.0001). Furthermore, GSTT1-AS1 (r = 0.313, p = 0.027) and (IFNG r = 0.478, p < 0.0001) demonstrated a significant positive correlation with age at onset.Briefly, the current study provided for the first time dysregulation of GSTT1-AS1 and IFNG-AS lncRNAs network in MS, which highlights the significant role of epigenetic pathways in this autoimmune disorder. Larger sample size and further investigation assays could shed light on the underlying mechanisms in this area of science.

Entities:  

Keywords:  GSTT1-AS1; IFNG; IFNG-AS; Multiple sclerosis; TNF

Mesh:

Substances:

Year:  2019        PMID: 30680474     DOI: 10.1007/s10072-019-3720-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  39 in total

Review 1.  Noncoding RNAs, cytokines, and inflammation-related diseases.

Authors:  José Luiz Marques-Rocha; Mirian Samblas; Fermin I Milagro; Josefina Bressan; J Alfredo Martínez; Amelia Marti
Journal:  FASEB J       Date:  2015-06-11       Impact factor: 5.191

2.  Myxovirus resistance protein A (MxA) polymorphism is associated with IFNβ response in Iranian multiple sclerosis patients.

Authors:  Arezou Sayad; Soudeh Ghafouri-Fard; Mir Davood Omrani; Rezvan Noroozi; Mohammad Taheri
Journal:  Neurol Sci       Date:  2017-04-06       Impact factor: 3.307

Review 3.  Immunopathology of multiple sclerosis.

Authors:  Calliope A Dendrou; Lars Fugger; Manuel A Friese
Journal:  Nat Rev Immunol       Date:  2015-08-07       Impact factor: 53.106

4.  HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis.

Authors:  Mehrdokht Mazdeh; Mohammad Taheri; Arezou Sayad; Siamak Bahram; Mir Davood Omrani; Abolfazl Movafagh; Hidetoshi Inoko; Mohammad Taghi Akbari; Rezvan Noroozi; Mehrdad Hajilooi; Ghasem Solgi
Journal:  Pharmacogenomics       Date:  2016-03-29       Impact factor: 2.533

5.  Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis.

Authors:  M Chofflon; C Juillard; P Juillard; G Gauthier; G E Grau
Journal:  Eur Cytokine Netw       Date:  1992 Nov-Dec       Impact factor: 2.737

Review 6.  [Diagnosis of multiple sclerosis: A review of the 2017 revisions of the McDonald criteria].

Authors:  Tünde Csépány
Journal:  Ideggyogy Sz       Date:  2018-09-30       Impact factor: 0.427

7.  The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-γ locus.

Authors:  J Antonio Gomez; Orly L Wapinski; Yul W Yang; Jean-François Bureau; Smita Gopinath; Denise M Monack; Howard Y Chang; Michel Brahic; Karla Kirkegaard
Journal:  Cell       Date:  2013-02-14       Impact factor: 41.582

Review 8.  Multiple sclerosis-A disease on a dramatically rising trend in Iran: Review of possible reasons.

Authors:  Mohammad Ali Sahraian; Mohammad Sahebkar; Rouhullah Dehghani; Milad Derakhshan-Jazari; Vahid Kazami-Moghaddam; Ebrahim Kouchaki
Journal:  Iran J Neurol       Date:  2017-01-05

9.  Evidence for cytokine dysregulation in multiple sclerosis: peripheral blood mononuclear cell production of pro-inflammatory and anti-inflammatory cytokines during relapse and remission.

Authors:  Robert D Hollifield; Laurence S Harbige; Danielle Pham-Dinh; Mohammed K Sharief
Journal:  Autoimmunity       Date:  2003-05       Impact factor: 2.815

10.  The Long Noncoding RNA IFNG-AS1 Promotes T Helper Type 1 Cells Response in Patients with Hashimoto's Thyroiditis.

Authors:  Huiyong Peng; Yingzhao Liu; Jie Tian; Jie Ma; Xinyi Tang; Ke Rui; Xinyu Tian; Chaoming Mao; Liwei Lu; Huaxi Xu; Pengcheng Jiang; Shengjun Wang
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

View more
  5 in total

1.  Dysregulation of long noncoding RNA MEG3 and NLRC5 expressions in patients with relapsing-remitting multiple sclerosis: is there any correlation?

Authors:  Shahram Torkamandi; Shima Bahrami; Tahereh Ghorashi; Mohammad Dehani; Hadi Bayat; Seyyed Mohamad Hoseini; Somaye Rezaei; Mohsen Soosanabadi
Journal:  Genes Immun       Date:  2021-11-15       Impact factor: 2.676

Review 2.  What do we know about the role of lncRNAs in multiple sclerosis?

Authors:  Viviana Nociti; Massimo Santoro
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

3.  Scavenging the hidden impacts of non-coding RNAs in multiple sclerosis.

Authors:  Aya A Elkhodiry; Hend M El Tayebi
Journal:  Noncoding RNA Res       Date:  2021-12-07

4.  Epigenetic modifications of tumor necrosis factor-alpha in joint cartilage tissue from osteoarthritis patients - CONSORT.

Authors:  Qiang Zhang; Zhengxiao Ouyang; Xiaoxia Song; Wei Zhu; Xinqiao Tang; Zhong Liu; Xiaoming Chen
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

Review 5.  Long Non-Coding RNAs, Novel Offenders or Guardians in Multiple Sclerosis: A Scoping Review.

Authors:  Abbas Jalaiei; Mohammad Reza Asadi; Hani Sabaie; Hossein Dehghani; Jalal Gharesouran; Bashdar Mahmud Hussen; Mohammad Taheri; Soudeh Ghafouri-Fard; Maryam Rezazadeh
Journal:  Front Immunol       Date:  2021-12-07       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.